全球微生物检测市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球微生物检测市场 – 行业趋势及 2030 年预测

  • Healthcare
  • Upcoming Report
  • Oct 2024
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Microbiology Testing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 5.02 Billion
Diagram Market Size (Forecast Year)
USD 10.09 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Cerner Corporation
  • Medtronic
  • Masimo
  • Koninklijke Philips N.V.
  • General Electric

>全球微生物学检测市场,按检测类型(细菌、病毒、真菌)、产品(仪器、试剂)、适应症(呼吸系统疾病、血流感染、胃肠道疾病、性传播疾病、泌尿道感染、牙周疾病、其他)、应用(制药应用、食品检测应用、临床应用、能源应用、化学和材料制造应用、环境应用)、最终用户(医院和诊断中心、定制实验室服务提供商、学术和研究机构)划分 - 行业趋势和预测到 2030 年。

微生物检测市场

微生物检测市场分析及规模

越来越多的有氧和厌氧测试为微生物学测试的发展铺平了道路。根据世界卫生组织的数据,美国每年约有 700 万人感染流感。这为与微生物学测试相关的研发能力创造了巨大的增长空间。政府在加强诊断和测试过程方面的几项新政策最终将导致微生物学测试的增长,因为它是测试病毒的重要组成部分。

Data Bridge Market Research 分析,微生物学检测市场规模将从 2022 年的 46.1 亿美元增至 2030 年的 92.6 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 9.1%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

微生物学检测市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

检测类型(细菌、病毒、真菌)、产品(仪器、试剂)、适应症(呼吸道疾病、血流感染、胃肠道疾病、性传播疾病、泌尿道感染、牙周疾病、其他)、应用(制药应用、食品检测应用、临床应用、能源应用、化学和材料制造应用、环境应用)、最终用户(医院和诊断中心、定制实验室服务提供商、学术和研究机构)

覆盖国家

U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Cerner Corporation (U.S.), Medtronic (Ireland), Masimo (U.S.), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Stryker (U.S.), iHealth Labs Inc., (U.S.), Cisco (U.S.), Silicon & Software Systems Ltd. (Ireland), Spectrum Medical (U.K.), Hill-Rom Services Inc. (U.S.), Iatric Systems Inc. (U.S.), Silex Technology America, Inc. (Japan), Digi International Inc. (U.S.), Baxter (U.S.), TE Connectivity (Switzerland), and Medicollector (U.S.)

Market Opportunities

  • Increasing Funding by Organizations
  • Growing Number of Collaborations between Market Players

Market Definition

Microbiology testing is an analytical technique used to determine the microorganisms in numerous samples such as biological, food and beverage, and environmental samples. Microbiology testing uses numerous chemical, biological, molecular, and biochemical methods. It is majorly applied to disease-causing and spoilage microorganisms. Among all other tests, three are the most common: polymerase chain reaction testing, immunoassays, and culture media.

Global Microbiology Testing Market Dynamics

Drivers

  • Growing Cases of STD

The huge increase in the STD rate demands rapid use of microbiology testing. According to the data published by the WHO, more than 1 million sexually transmitted infections are acquired worldwide each day; most of them will be asymptomatic in 2022. It also stated that there are around 374 million new infections yearly, with 1 out of 4 sexually transmitted infections such as chlamydia, trichomoniasis, gonorrhea, and syphilis. These diseases need immediate testing to identify the responsible virus for faster treatment processes. Thus, this factor boosts market growth.

  • Increasing Strategic Product Launches Associated with Microbiology Testing

The growing incidence of infectious diseases and several strategies adopted by major market players, such as product launches and expansions of services, are anticipated to drive the growth of the microbiology testing market. For instance, STEMart launched microbiology and sterility testing for sterile and non-pyrogenic medical devices in 2022. Therefore, growing service launches by major market players are anticipated to improve market growth during the forecast period. Thus, this factor boosts market growth.

Opportunities

  • Increasing Funding by Organizations

Increasing government and private funds for research and development boost the market's growth. For instance, the Department of Science and Technology (DST), India, announced funding of around USD 26.42 million to several scientific institutions, startups, and industries to develop new advanced innovative solutions to fight the COVID-19 pandemic in 2020. These solutions involve rapid and accurate diagnosis kits, protection equipment, and other necessary solutions. Thus, this factor boosts market growth.  

  • Growing Number of Collaborations between Market Players

Several market players collaborate with small companies to invest in their new innovative technologies and develop new infectious disease tests. For instance, CSL Behring, a U.S. biotherapeutics company, and South Dakota-based SAB Therapeutics collaborated with each other for clinical trials of its antibody-based treatment SAB-185 on COVID-19 patients. Thus, this type of collaboration enhances market growth.

Restraints/Challenges

  • Limited Reimbursement in Developing Regions

In many countries, late reimbursement is a major barrier to market growth. Reimbursement for microbiology testing is a complex process. The reimbursement process's complexity is a major hindrance for this market. Furthermore, several countries' lack of standardized reimbursement policies impedes the market growth. Therefore, the lack of reimbursement in emerging nations hampers the market growth.

  • Lack of Accuracy of Tests

It has been witnessed many times that testing kits and devices can show false-negative results. The microbial testing kits often lack accuracy due to improper sample loading and unloading. This lack of accuracy in microbiology testing is estimated to restrain the market's growth.

This microbiology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microbiology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2022, IDEXX acquired Tecta-PDS, an innovative Canadian company that has launched automation to water microbiology testing for parameters including E. coli and total coliforms. The acquisition assisted IDEXX in increasing its range of water microbiology testing options for both laboratory-based and in-field testing.
  • In 2022, Archer Daniels Midland (ADM) launched a new microbiology laboratory at its ADM Specialty Manufacturing facility in Decatur, Illinois. The project expanded the site's microbiology laboratory footprint on a huge scale and increased the location's testing capabilities.

Global Microbiology Testing Market Scope

The microbiology testing market is segmented on the basis of test type, product, indication, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Bacterial
  • Viral
  • Fungal

Products

  • Instruments
  • Laboratory Instruments
  • Incubators
  • Gram Strainers
  • Bacterial Colony Counters
  • Autoclave Sterilizers
  • Microbial Air Samplers
  • Anaerobic Culture Systems
  • Petri Dish Fillers
  • Blood Culture Systems
  • Microbial Culture Systems
  • Others
  • Microbiology Analyzers
  • Molecular Diagnostic Instruments
  • Microscopes
  • Mass Spectrometers
  • Reagents
  • Pathogen-Specific Kits
  • General Reagents

Indication

  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infection
  • Periodontal Diseases
  • Others

Application

  • Pharmaceutical
  • Food Testing
  • Clinical
  • Energy
  • Chemical and Material Manufacturing
  • Environmental

End User

  • Hospitals and Diagnostic Centers
  • Custom Lab Service Providers
  • Academic and Research Institutes

Microbiology Testing Market Regional Analysis/Insights

The microbiology testing market is analyzed and market size insights and trends are provided by test type, product, indication, application and end user as referenced above.

The countries covered in the microbiology testing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the microbiology testing market because of the huge base of healthcare facilities, increasing investment from major market players in the growth of advanced devices. Also, well-established distribution channels for clinical microbiology product manufacturers, and a growing number of research activities further boost the market growth.

Asia-Pacific is expected to witness significant growth due to the rise in government initiatives to raise awareness and favorable regulatory policies to increase the adoption rate for microbiology testing. Also, other advanced diagnostic methods, and the higher demand for quality healthcare in the region.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

微生物检测市场还为您提供每个国家/地区资本设备医疗保健支出增长、微生物检测市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对微生物检测市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。

竞争格局和微生物学检测市场份额分析

微生物检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对微生物检测市场的关注有关。

微生物学检测市场的一些主要参与者包括:

  • Cerner Corporation(美国)
  • 美敦力(爱尔兰)
  • Masimo(美国)
  • Koninklijke Philips NV(荷兰)
  • 通用电气(美国)
  • 史赛克(美国)
  •  iHealth Labs Inc.,(美国)
  • 思科 (美国)
  • Silicon & Software Systems Ltd.(爱尔兰)
  • Spectrum Medical(英国)
  • Hill-Rom Services Inc.(美国)
  • Iatric Systems Inc.(美国)
  • Silex Technology America, Inc.(日本)
  • Digi International Inc.(美国)
  • 百特(美国)
  • TE Con​​nectivity (瑞士)
  • Medicolector(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Test Type (Bacterial, Viral, and Fungal), Product (Instruments, and Reagents), Indication (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, and Others), Application (Pharmaceutical Applications, Food Testing Applications, Clinical Applications, Energy Applications, Chemical and Material Manufacturing Applications, and Environmental Applications), End User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes) – Industry Trends and Forecast to 2031 .
The Global Microbiology Testing Market size was valued at USD 5.02 USD Billion in 2023.
The Global Microbiology Testing Market is projected to grow at a CAGR of 9.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Cerner Corporation, Medtronic, Masimo, Koninklijke Philips N.V., General Electric, Stryker, iHealth Labs , Cisco, Silicon & Software Systems , Spectrum Medical, Hill-Rom Services , Iatric Systems , Silex Technology America , Digi International , Baxter, TE Connectivity, Medicollector,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..